Aziz Faisal, Lehman Erik B
Division of Vascular Surgery, Penn State Heart and Vascular Institute, Pennsylvania State University College of Medicine, Hershey, PA.
Department of Public Health Sciences, Pennsylvania State University, College of Medicine, Hershey, PA.
Ann Vasc Surg. 2018 Jul;50:60-72. doi: 10.1016/j.avsg.2018.01.075. Epub 2018 Feb 24.
Readmissions after surgical procedures are increasingly considered a metric to indicate the quality of care received during the index hospitalization. Patients with peripheral arterial disease (PAD) requiring peripheral vascular interventions (PVIs) or lower extremity bypasses (LEBs) often have several serious medical comorbidities. Risk factors associated with readmission after PVI and LEB have previously been identified. The purpose of this study is to compare the readmissions among patients receiving PVI and LEB procedures to identify risk factors associated with high risk of readmission.
The 2013 Procedure-targeted American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database and generalized 2013 general and vascular surgery ACS-NSQIP Program User Files were used for this study. Patient, diagnosis, and procedure characteristics of patients undergoing PVI and LEB were assessed. Odds ratios (ORs) with confidence intervals (CIs) for PVI versus LEB groups within the subgroups of these characteristics were then obtained where significant associations existed between the study groups.
A total of 3,742 patients (males: 2,384 [63.7%] and females: 1,358 [36.3%]) underwent surgical procedures for lower extremity PAD during the year 2013. Among these patients, 1,096 (29.3%) were treated with endovascular interventions and 2,646 (70.7%) were treated with surgical bypasses. Patients were divided into 2 groups: PVI (n = 1,096) and LEB (n = 2,646) groups. Each group was further subdivided into 2 groups: readmission and no readmission. The incidence of readmission was as follows: PVI group (n = 147, 13.4%) and LEB (n = 425, 16.1%). The PVI and LEB groups showed a significant association with readmission within the following factors: dialysis dependency (PVI 32.6% vs. LEB 19.1%, OR: 2.06, CI: 1.13-3.75, P < 0.001), emergency operation (PVI 40.4% vs. LEB 18.7%, OR: 2.96, CI: 1.45-6.03, P < 0.001), chronic obstructive pulmonary disease (COPD; PVI 23.7% vs. LEB 14.6%, OR: 1.82, CI: 1.08-3.07, P = 0.001), cardiac arrest (PVI 45.5% vs. LEB 9.5%, OR: 7.92, CI: 1.21-51.9, P = 0.017), and body mass index > 30 (PVI 9.9% vs. LEB 18.4%, OR: 0.49, CI: 0.33-0.73, P = 0.009).
Readmissions after lower extremity endovascular or surgical interventions can be used as a quality metric. Patients with dialysis dependency, COPD, in need of emergent operation, or having cardiac arrest are highly likely to be readmitted if treated with endovascular interventions. Similarly, patients with high body mass index are highly likely to be readmitted if treated with open surgical bypasses.
外科手术后的再入院情况越来越被视为衡量首次住院期间所接受护理质量的一项指标。需要进行外周血管介入治疗(PVI)或下肢搭桥手术(LEB)的外周动脉疾病(PAD)患者通常伴有多种严重的内科合并症。此前已确定了与PVI和LEB术后再入院相关的风险因素。本研究的目的是比较接受PVI和LEB手术的患者的再入院情况,以确定与再入院高风险相关的风险因素。
本研究使用了2013年以手术为目标的美国外科医师学会国家外科质量改进计划(ACS - NSQIP)数据库以及2013年广义的普通外科和血管外科ACS - NSQIP计划用户文件。评估了接受PVI和LEB手术患者的患者、诊断和手术特征。然后在这些特征的亚组中,针对PVI组与LEB组获得了带有置信区间(CI)的比值比(OR),前提是研究组之间存在显著关联。
2013年共有3742例患者(男性:2384例[63.7%],女性:1358例[36.3%])接受了下肢PAD的外科手术。在这些患者中,1096例(29.3%)接受了血管内介入治疗,2646例(70.7%)接受了外科搭桥手术。患者被分为两组:PVI组(n = 1096)和LEB组(n = 2646)。每组又进一步细分为两组:再入院组和未再入院组。再入院发生率如下:PVI组(n = 147,13.4%)和LEB组(n = 425,16.1%)。PVI组和LEB组在以下因素方面与再入院存在显著关联:透析依赖(PVI组为32.6%,LEB组为19.1%,OR:2.06,CI:1.13 - 3.75,P < 0.001)、急诊手术(PVI组为40.4%,LEB组为18.7%,OR:2.96,CI:1.45 - 6.03,P < 0.001)、慢性阻塞性肺疾病(COPD;PVI组为23.7%,LEB组为14.6%,OR:1.82,CI:1.08 - 3.07,P = 0.001)、心脏骤停(PVI组为45.5%,LEB组为9.5%,OR:7.92,CI:1.21 - 51.9℃,P = 0.017)以及体重指数> 30(PVI组为9.9%,LEB组为18.4%,OR:0.49,CI:0.33 - 0.73,P = 0.009)。
下肢血管内或外科手术后的再入院情况可作为一项质量指标。有透析依赖、COPD、需要急诊手术或发生心脏骤停的患者,如果接受血管内介入治疗,很可能再次入院。同样,体重指数高的患者,如果接受开放外科搭桥手术,也很可能再次入院。